BDBM466502 US10799605, Example 13

SMILES COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccc(C(=O)N(C)CCCN(C)CCCN(C)C(=S)Nc2ccc(NC(=S)NCCCCCN(O)C(=O)CCC(=O)NCCCCCN(O)C(=O)CCC(=O)NCCCCCN(O)C(C)=O)cc2)cc1C(C)C

InChI Key InChIKey=DAIZLYZFLGBECH-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 466502   

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 466502BDBM466502(US10799605, Example 13)
Affinity DataIC50: 3nMAssay Description:In order to determine the binding affinity of compounds comprising a radiolabel for NTR1, a radioligand binding assay was carried out. A radioligand ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 466502BDBM466502(US10799605, Example 13)
Affinity DataIC50: 17.5nMAssay Description:Ca2+ ions are usually kept at nanomolar levels in the cytosol of cells, and act in a number of signal transduction pathways as second messengers. Man...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent